U.S. Epigenetics Market 2030: The Impact of COVID-19 on Research Trends
The U.S. epigenetics market size was estimated at USD 5.13 billion in 2023 and is projected to witness a CAGR of 14.5% from 2024 to 2030. This growth can be attributed to the pivotal role of epigenetics in understanding gene regulation beyond DNA sequencing, aiding disease research, and advancing personalized medicine. The established companies and startups operating in the industry are investing significantly to develop the epigenetics domain. The epigenetics market has been significantly influenced by the COVID-19 pandemic. The growing understanding of the intricate relationship between the SARS-CoV-2 virus and epigenetic mechanisms has highlighted the potential for using epigenetic treatments to fight the virus. With the current lack of antiviral drugs that are clinically approved, there's a window for industry participants to investigate new methods. This includes the combination of antiviral medications with DNMT/HDAC inhibitors and other epigenetic therapies. Should these i...